An organ-on-a-chip (OOC) is a microfluidic cell culture device created using microchip manufacturing methods that includes continuously perfused chambers inhabited by living cells and arranged to simulate tissue- and organ-level physiology. This chip creates a narrow channel for blood and air flow in organs such as the lung, intestine, liver, and heart, among others. These devices generate multiple levels of tissue and organ functionality that are not possible with traditional 2D and 3D culture systems. Organ-on-chip technology can be used for a variety of purposes, including disease modelling, patient stratification, and phenotypic screening.
The Organ-On-Chip Market is divided into type, offerings, application, end user, and region in this report. The organs-on-chips market is classified into liver, lung, heart, kidney, and other organs-on-chips. The accessories segment is expected to account for the majority of the organs-on-chips market in 2017. This segment's large share can be attributed to the model's simplicity and the ability of on-chip hepatic tissues to maintain metabolic activity and phenotype similar to the in vivo environment. The organs-on-chips market is divided into three applications: physiological model development, drug discovery, and toxicology research. During the forecast period, the drug discovery segment is expected to have the highest CAGR.
Read More@ https://bit.ly/3xZXMGC
